Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03881397 · ClinicalTrials.gov registry record · NA

Youth Health and Social Media

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
1,520
Enrollment target

NCT03881397: Completed NA study, sponsored by University of Wisconsin, Madison.

NCT03881397 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 1,520 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03881397, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
1,520 participants
Enrollment target

Study Summary

The purpose of this study is test the American Academy of Pediatrics (AAP) Family Media Use plan among teens and their parents through a randomized intervention and assess impact on outcomes including family media rules and health behavior outcomes.

Primary Outcome

Increases in the number of positive responses to technology and media rules followed or maintained

Interventions

  • BEHAVIORAL Family Media Use Plan
  • BEHAVIORAL Media Use Resources Awareness

Trial Details

FieldValue
Enrollment Target 1,520 participants
Start Date 2019-04-04
Est. Completion 2020-02-26
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT03881397 record still lists

NCT03881397 is an interventional study that assigns participants to a tested intervention. Its 1,520 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.

The record links to 0 conditions, and to 2 interventions - of which Family Media Use Plan is the first listed.

NCT03881397 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03881397 about?

NCT03881397 is a clinical study titled "Youth Health and Social Media". The purpose of this study is test the American Academy of Pediatrics (AAP) Family Media Use plan among teens and their parents through a randomized intervention and assess impact on outcomes including family media rules and health behavior outcomes.

What is the current status of trial NCT03881397?

This trial is currently completed. It is a NA study. The enrollment target is 1,520 participants. The study started on 2019-04-04. Estimated completion is 2020-02-26.

What interventions are being tested in trial NCT03881397?

The interventions under investigation include: Family Media Use Plan (BEHAVIORAL), Media Use Resources Awareness (BEHAVIORAL).

Who is sponsoring clinical trial NCT03881397?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03881397's enrollment target sits among peer trials

1,520 65th of 2000 higher than 1,936 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07232017 · 1,520 participants

    Implementation of Intensive Hypertension Management Approaches: Cleveland Clinic

  • NCT06876714 · 1,524 participants · Phase 3

    ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

  • NCT06257082 · 1,526 participants · NA

    Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities

  • NCT05633654 · 1,514 participants · Phase 3

    Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03881397, the US trial registry maintained by the National Library of Medicine. NCT03881397 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.